These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23380910)

  • 1. Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone.
    Irwin DJ; Abrams JY; Schonberger LB; Leschek EW; Mills JL; Lee VM; Trojanowski JQ
    JAMA Neurol; 2013 Apr; 70(4):462-8. PubMed ID: 23380910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
    Ritchie DL; Adlard P; Peden AH; Lowrie S; Le Grice M; Burns K; Jackson RJ; Yull H; Keogh MJ; Wei W; Chinnery PF; Head MW; Ironside JW
    Acta Neuropathol; 2017 Aug; 134(2):221-240. PubMed ID: 28349199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.
    Purro SA; Farrow MA; Linehan J; Nazari T; Thomas DX; Chen Z; Mengel D; Saito T; Saido T; Rudge P; Brandner S; Walsh DM; Collinge J
    Nature; 2018 Dec; 564(7736):415-419. PubMed ID: 30546139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977.
    Abrams JY; Schonberger LB; Belay ED; Maddox RA; Leschek EW; Mills JL; Wysowski DK; Fradkin JE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1666-9. PubMed ID: 21816775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.
    Kotzbauer PT; Cairns NJ; Campbell MC; Willis AW; Racette BA; Tabbal SD; Perlmutter JS
    Arch Neurol; 2012 Oct; 69(10):1326-31. PubMed ID: 22825369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-cerebral haemorrhage but not neurodegenerative disease appears over-represented in deaths of Australian cadaveric pituitary hormone recipients.
    Alnakhli SH; Wand H; Law M; Sarros S; Stehmann C; Senesi M; Klug GM; Simpson M; Lewis V; Masters CL; Collins SJ
    J Clin Neurosci; 2020 Nov; 81():78-82. PubMed ID: 33222975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.
    Cali I; Cohen ML; Haik S; Parchi P; Giaccone G; Collins SJ; Kofskey D; Wang H; McLean CA; Brandel JP; Privat N; Sazdovitch V; Duyckaerts C; Kitamoto T; Belay ED; Maddox RA; Tagliavini F; Pocchiari M; Leschek E; Appleby BS; Safar JG; Schonberger LB; Gambetti P
    Acta Neuropathol Commun; 2018 Jan; 6(1):5. PubMed ID: 29310723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.
    Duyckaerts C; Sazdovitch V; Ando K; Seilhean D; Privat N; Yilmaz Z; Peckeu L; Amar E; Comoy E; Maceski A; Lehmann S; Brion JP; Brandel JP; Haïk S
    Acta Neuropathol; 2018 Feb; 135(2):201-212. PubMed ID: 29209767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
    Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
    Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
    Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
    Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.
    Doorn KJ; Goudriaan A; Blits-Huizinga C; Bol JG; Rozemuller AJ; Hoogland PV; Lucassen PJ; Drukarch B; van de Berg WD; van Dam AM
    Brain Pathol; 2014 Mar; 24(2):152-65. PubMed ID: 24033473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.
    Arnold SE; Lee EB; Moberg PJ; Stutzbach L; Kazi H; Han LY; Lee VM; Trojanowski JQ
    Ann Neurol; 2010 Apr; 67(4):462-9. PubMed ID: 20437581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?
    Beekes M; Thomzig A; Schulz-Schaeffer WJ; Burger R
    Acta Neuropathol; 2014 Oct; 128(4):463-76. PubMed ID: 25073522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides.
    Kumar D; Kumar P
    Neuropeptides; 2019 Dec; 78():101971. PubMed ID: 31540705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?
    Kovacs GG
    Prion; 2016 Sep; 10(5):369-376. PubMed ID: 27649940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.